SAP? [Software]

posted by Mahmoud  – Jordan, 2020-07-03 17:17 (293 d 20:36 ago) – Posting: # 21648
Views: 1,621

Dear Dr
=======
Thank you very much for your information

in This study I found that and for Cmax Pk that

CVintra =27.3217 and CVinter=20.7271 this is not true in BE studies

From most studies CVinter is more more than CVintra

I think that the two types=CSH or FA0(1) in the FDA code are not suitable to obtain these results

» Are you trying to “safe” a failed study?

No


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

Activity
 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 14 (0 registered, 14 guests [including 2 identified bots]).
Forum time: Friday 13:53 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5